Pharmaceuticals
Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development
Collaboration Shifts Focus to Personalized Software Dashboards for Enhanced Efficiency Conduit Pharmaceuticals (CDT) announced the successful completion of Phase I...
Walgreens Halts 92-Year Dividend to Strengthen Finances
Shares Plunge 15% as Retail Pharmacy Giant Focuses on Turnaround Walgreens Boots Alliance (WBD) saw its stock tumble 15% on...
Telomir Pharmaceuticals Unveils Groundbreaking Results with Telomir-1: A New Hope for Combating Oxidative Stress and Viral Infections
Innovative drug shows potential to address aging, chronic diseases, and avian influenza through oxidative stress reversal Telomir Pharmaceuticals (TELO), a...
Alpha Cognition Secures $44 Million Licensing Deal with CMS for ZUNVEYL in Asia-Pacific
Agreement Paves the Way for Advanced Alzheimer’s Treatment in China and Beyond Alpha Cognition (ACOG), a biopharmaceutical company at the...
Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study
Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has...
Traws Pharma Advances Bird Flu Treatment with Promising Phase 1 Results
Tivoxavir Marboxil Shows Potent Protection Against H5N1 in Preclinical and Early Clinical Studies Traws Pharma (TRAW), a clinical-stage biopharmaceutical company,...
Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease
Emerging Findings Position Telomir-1 as a Promising Solution for Copper Metabolism Disorders and Expand Its Potential Applications Telomir Pharmaceuticals (TELO),...
MIRA Pharmaceuticals Advances Ketamir-2: A Safe Step Forward in Neuropathic Pain Treatment
Favorable safety results pave the way for Phase 1 human trials in early 2025, offering hope for millions seeking non-addictive...
Telomir Pharmaceuticals Unveils Groundbreaking Results in Age-Reversal Science with Telomir-1
Preclinical Study Highlights Significant Longevity Benefits, Sets Stage for Human Trials Telomir Pharmaceuticals (Nasdaq: TELO) has announced groundbreaking preclinical results...
BioMarin Pharmaceuticals’ New Strategy Promises Strong Upside, Led by Voxzogo and Roctavian
Wedbush Sees Favorable Risk/Reward as BioMarin Targets Growth in Rare Disease Market BioMarin Pharmaceuticals (BMRN), a leader in rare disease...
